Depsides and depsidones
Medchemexpress LLC Ethyl benzoate | 93-89-0 | MFCD00009109 | 99.9% | 150.17 g/mol | C9H10O2 | 1 ML
Ethyl benzoate is an organic ester (C9H10O2) provided as a ready-to-use 10 mM solution in DMSO for research and analytical applications. It is used as a reference standard and reagent for analytical method development, chromatography, and biochemical assays that require a defined concentration and high purity (CAS 93-89-0).
- Ready-to-use 10 mM solution in DMSO.
- High purity suitable for analytical use.
- Convenient 1 mL volume for small-scale assays.
- Accompanied by safety data and certificate of analysis.
- Suitable for chromatography and method development as a reference standard.
Medchemexpress LLC Fotagliptin benzoate | 1403496-40-1 | 99.2% | 464.49 g·mol⁻1 | C24H25FN6O3 | 5MG
Fotagliptin benzoate is a research-grade dipeptidyl peptidase-4 (DPP-4) inhibitor provided as the benzoate salt for preclinical and biochemical studies related to type 2 diabetes research. It is supplied as a solid powder and in small analytical vial sizes for laboratory use.
Medchemexpress LLC Alogliptin (Benzoate) | 850649-62-6 | 99.98% | C25H27N5O4 | 1 ML
Alogliptin Benzoate (SYR-322) is a potent, selective, and orally active inhibitor of DPP-4, primarily used for research related to type 2 diabetes. It exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.
- Potent and selective DPP-4 inhibitor
- Orally active
- Used for type 2 diabetes research
- Inhibits LPS-induced ERK phosphorylation in U937 cells
- Reduces infarction area and improves brain vascular integrity in MCAO mice
Medchemexpress LLC Alogliptin (benzoate) | 850649-62-6 | 99.98% | C25H27N5O4 | 500 MG
Alogliptin Benzoate (SYR-322) is a potent, selective, and orally active inhibitor of DPP-4 with an IC50 of <10 nM. It exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9 and can be used for the research of type 2 diabetes.
- Potent, selective, and orally active DPP-4 inhibitor
- High selectivity (greater than 10,000-fold) over DPP-8 and DPP-9
- Useful for research into type 2 diabetes
Medchemexpress LLC Phenyl benzoate | 93-99-2 | MFCD00003072 | 100.0% | 198.22 | 100 G
Phenyl benzoate is a benzoate ester formed by the formal condensation of phenol with benzoic acid. It acts as a chloride transport blocker, inhibiting chloride-dependent glutamate accumulation into vesicles. Additionally, it can be used as a preservative in cosmetic products.
- Chloride transport blocker
- Inhibits Cl--dependent Glu accumulation into vesicles
- Can be used as a preservative in cosmetic products
Medchemexpress LLC Ethyl benzoate | 93-89-0 | MFCD00009109 | 99.9% | 150.18 g·mol⁻¹ | C9H10O2 | 500 G
Ethyl benzoate is the ethyl ester of benzoic acid, a colorless liquid used as a reagent, solvent, fragrance component, and analytical standard. It is supplied for research use and characterized by high gas-chromatography purity.
eMolecules 552-94-3 | 2-((2-Hydroxybenzoyl)oxy)benzoic acid | Combi-Blocks, Inc. | MFCD00020252 | 258.229 | C14H10O5 | 98.000 | OC(=O)c1ccccc1OC(=O)c1ccccc1O | 25g | 603138634
2-((2-Hydroxybenzoyl)oxy)benzoic acid | Combi-Blocks, Inc. | 552-94-3 | MFCD00020252 | 258.229 | C14H10O5 | 98.000 | OC(=O)c1ccccc1OC(=O)c1ccccc1O | 25g | 603138634
Selleck Chemical LLC Emamectin Benzoate S4423-100mg
Emamectin Benzoate (EMB MK-244) activates gamma-amino butyric acid (GABA) transporter Emamectin Benzoate induces of reactive oxygen species (ROS)-mediated DNA damage and apoptosis
Medchemexpress LLC SOR-C13 | 1187852-48-7 | 99.1% | 1565.81 | 5 MG
SOR-C13 is a carboxy-terminal truncated peptide, functioning as a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel associated with malignancy and poor prognosis in breast cancer. SOR-C13 demonstrates anticancer activity.
- Functions as a high-affinity TRPV6 antagonist
- Has an IC50 value of 14 nM against TRPV6
- Associated with anticancer activity
- Inhibits tumor growth in female NOD/SCID mice with SKOV-3 cells
Medchemexpress LLC Sor-c13 TFA | 1187852-48-7 | 99.3% | 1565.81 | 25 MG
SOR-C13 TFA is a carboxy-terminal truncated peptide. It functions as a high-affinity TRPV6 antagonist with an IC50 value of 14 nM. TRPV6 is a non-voltage gated calcium channel associated with malignancy and poor prognosis in breast cancer. SOR-C13 TFA exhibits anticancer activity.
- High-affinity TRPV6 antagonist with an IC50 value of 14 nM.
- Associated with malignancy and poor prognosis in breast cancer.
- Exhibits anticancer activity.
- For research use only.
- Not for sale to patients.